RESPONDER-HF Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 750 participants.
Also called NCT05425459
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 750 participants
- Sponsor
- Corvia Medical
- Registry
-
NCT05425459
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Austria, Belgium, Canada, Germany, Netherlands
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05425459. Randomized; triple masking; primary purpose treatment. Start 2022-11-17 (actual); primary completion 2027-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- RESPONDER-HF Trial
- Condition
- Heart Failure
- Condition
- Heart Failure, Diastolic
- Intervention (Device)
- Corvia Atrial Shunt System / IASD System II
- Intervention (Other)
- Intra-cardiac echocardiography (ICE), or transesophageal echocardiography (TEE)
- Lead sponsor
- Corvia Medical
Record details
- Record id
cardio:ct-nct05425459- Content hash
5299fe6bffc26b747c8a9ce49b1cc3c225a7d6d351072322b234360e7c9b902c